McCreedy Bruce J Jr.
Known title: DirectorCIK: 0001769750
Associated companies
Transaction History
| DCOY | ▲ Buy | Grant | 1,440 | $0 | 1/3/2023 | View on chart |
| DCOY | ▲ Buy | Grant | 1,440 | $0 | 1/3/2023 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
DCOY Reports Preclinical Data for Once-Weekly Dosing
Decoy Therapeutics released preclinical data supporting a once-weekly intranasal dosing schedule for its DCOY-CoV program. The company is also scheduled to present at The Small Cap Showcase investor conference. These updates provide context for the stock's current trading levels, which sit near significant support.
DCOY Reports Preclinical Data for Once-Weekly Dosing. Decoy Therapeutics released preclinical data supporting a once-weekly intranasal dosing schedule for its DCOY-CoV program. The company is also scheduled to present at The Small Cap Showcase investor conference. These updates provide context for the stock's current trading levels, which sit near significant support.